Non-survivors (n = 19) | Survivors (n = 405) | p-value | |
---|---|---|---|
Preoperative characteristics | |||
Gender (male) | 11 (57.9 %) | 263 (64.9 %) | 0.62 |
Age (years) | 75 (56–87) | 70 (42–89) | 0.05 |
Parsonnet score | 30.5 (16.5–49) | 16.5 (0–52.5) | <0.0001 |
Congestive heart failure | 12 (63.2 %) | 170 (41.9 %) | 0.06 |
Renal failurea | 9 (47.4 %) | 42 (10.4 %) | <0.0001 |
Severe peripheral vascular disease | 5 (26.3 %) | 25 (6.2 %) | 0.007 |
Reoperation | 3 (15.8 %) | 8 (2 %) | 0.005 |
Chronic obstructive pulmonary diseaseb | 7 (36.8 %) | 51 (12.6 %) | .008 |
Postoperative characteristics | |||
Peak arterial lactate ≥3.0 mmol/L | 15 (78.9 %) | 129 (31.8 %) | <0.0001 |
Peak creatinine μmol/L | 127 (66–840) | 100 (39–1013) | <0.0001 |
Intra-aortic balloon pump | 6 (31.6 %) | 37 (9.2 %) | 0.008 |
CT chest /abdomen | 2 (10.5 %) | 2 (0.5 %) | 0.01 |
Return to OR | 5 (26.3 %) | 22 (5.4 %) | 0.005 |
Cardiogenic shock | 5 (26.3 %) | 6 (1.5 %) | <0.0001 |
Post-operative cardiac hemorrhage | 2 (10.5 %) | 11 (2.7 %) | 0.01 |
Acute kidney injury (AKIN 1) | 16 (84.2 %) | 125 (32.2 %) | <0.0001 |
Non-obstructive ileus | 1 (5.5 %) | 2 (0.5 %) | 0.13 |
Ischemic bowel | 1 (5.5 %) | 0 | 0.05 |